openPR Logo
Press release

Biomarkers Market Report- Application: Diagnostics, Drug Discovery & Development, Personalized Medicine | Global Forecast to 2026

07-28-2021 02:20 PM CET | Health & Medicine

Press release from: ReportsnReports

The in-depth analysis of the historical data provides the Biomarkers Market report offering vital information about the market status for the forecast period. Exhaustive research and analysis of the vital market segments such as, top market players across different geographical locations, their products and the end-users can help to understand the product trend, challenges, revenue, and growth factors. Biomarkers Market also provides meaningful insight regarding the market size, market status, growth rate, future trends, market drivers, opportunities and challenges etc. Further, the report delivers details regarding the restraints, channels, and distributors, sales dynamics, and profit margin etc for the Biomarkers Market .

Request for FREE PDF Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=145494

Top Company Profile Analysis in this Report- F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc. (US), Abbott Laboratories (US), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), ENZO BIOCHEM, INC. (US), Charles River Laboratories International, Inc. (US), Eurofins Scientific S.E. (Luxembourg), Meso Scale Diagnostics, LLC. (US), StressMarq Biosciences Inc. (US), DiaMetra Srl (Italy), Signosis, Inc. (US), bioMérieux SA (France), Axon Medchem BV (Netherlands), EKF Diagnostics Holdings, Plc (UK), MicroConstants, Inc. (US), NorthEast BioAnalytical Laboratories LLC. (US), Q2 Solutions LLC. (US), JSR Life Sciences, LLC (US), BioAgilytix Labs (US), Celerion (US), AnyGenes (US), and BiomarkerBay B. V. (Netherlands).

The global biomarkers market is expected to reach USD 78.1 billion in 2026 from USD 43.1 billion in 2021 at a CARG of 12.6%. Growth in the biomarkers market is mainly driven by factors such as the growing importance of companion diagnostics, increasing prevalence of cancer worldwide, growing funding activities for biomarker research, and product innovations.

The biomarkers market in the Asia Pacific region is projected to register the highest growth during the forecast period. The growth of this segment is primarily due to the increasing use of biomarkers for diagnostic purposes, the growing prevalence of chronic diseases, favorable government initiatives, and the growing focus on genomic & proteomic research projects.

The report segments the biomarkers market based on region (Asia Pacific, Europe, North America, and Rest of the World), product (consumables services, software), type (safety biomarkers, efficacy biomarkers [predictive biomarkers, surrogate biomarkers, pharmacodynamics biomarkers, prognostic biomarkers], and validation biomarkers, application (diagnostics, drug discovery & development Personalized medicine, disease risk assessment and other applications), and disease indications (cancer[solid biopsy, liquid biopsy], infectious diseases, immune disorders, neurological disorders, cardiovascular disorders, and other disease indications). The report also provides a comprehensive review of market drivers, restraints opportunities, challenges and trends in the biomarkers market.

Get FLAT 25% Discount on this Report @ https://www.reportsnreports.com/purchase.aspx?name=145494

Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the biomarkers market and provides them information on key market drivers, restraints, challenges, and opportunities.

Table Of Contents in this Report-
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.2.1 Inclusions & Exclusions
1.3 Market Scope
1.3.1 Markets Covered
Figure 1 Biomarkers Market Segmentation
1.3.2 Years Considered In The Report
1.4 Currency
1.5 Limitations
1.6 Stakeholders
1.7 Summary Of Changes

2 Research Methodology
2.1 Research Data
Figure 2 Research Design
2.1.1 Secondary Data
2.1.2 Primary Data
Figure 3 Primary Sources
Figure 4 Biomarkers Market: Breakdown Of Primaries
2.1.2.1 Key Industry Insights
2.2 Market Size Estimation
Figure 5 Market Size Estimation: Revenue Share Analysis, 2020
Figure 6 Market Size Estimation Methodology: Bottom-Up (Supply Side): Collective Revenue Of All Biomarkers Products
Figure 7 Biomarkers Market: Cagr Projections, 2021–2026
Figure 8 Biomarkers Market: Growth Analysis Of Drivers, Restraints Opportunities, And Challenges
2.3 Market Breakdown And Data Triangulation
Figure 9 Data Triangulation Methodology
2.4 Research Limitations
2.5 Research Assumptions
2.6 Risk Analysis

3 Executive Summary
Figure 10 Biomarkers Market, By Product & Service, 2021 Vs. 2026 (Usd Billion)
Figure 11 Biomarkers Market Share, By Type, 2020
Figure 12 Biomarkers Market, By Disease Indication, 2021 Vs. 2026 (Usd Billion)
Figure 13 Biomarkers Market, By Application, 2021−2026
Figure 14 Geographical Snapshot Of The Biomarkers Market

4 Premium Insights
4.1 Biomarkers Market Overview
Figure 15 The Growing Importance Of Companion Diagnostics Is A Key Factor Expected To Drive The Growth Of The Biomarkers Market
4.2 Asia Pacific: Biomarkers Market, By Product & Country (2020)
Figure 16 Consumables Accounted For The Largest Share Of The Asia Pacific Market In 2020
4.3 Efficacy Biomarkers Market, By Type, 2020
Figure 17 The Predictive Biomarkers Segment Is Projected To Witness The Highest Growth During The Forecast Period

5 Market Overview
and more...

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biomarkers Market Report- Application: Diagnostics, Drug Discovery & Development, Personalized Medicine | Global Forecast to 2026 here

News-ID: 2339708 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases


More Releases for Biomarkers

Biomarkers Market Soars: Safety Biomarkers Lead with 15.9% Projected Growth from …
The global biomarkers market size was valued at US$ 59.1 Billion in 2021 and is expected to expand at a compound annual growth rate CAGR of 15.3% from 2022 to 2032. Safety Biomarkers are expected to be the highest revenue generating biomarker type, with a projected growth of 15.9% from 2022-2032. Biomarkers, or biological indicators, have revolutionized the fields of medicine and healthcare by enabling early disease detection, personalized treatment, and
Neurological Biomarkers Market - Decoding Brain Health: Biomarkers Revolutionizi …
Newark, New Castle, USA: The "Neurological Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Neurological Biomarkers Market: https://www.growthplusreports.com/report/neurological-biomarkers-market/8040 This latest report researches the industry structure, sales, revenue,
Cardiac Biomarkers Market - Unveiling Heart Health: Biomarkers Revolutionizing C …
Newark, New Castle, USA: The "Cardiac Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cardiac Biomarkers Market: https://www.growthplusreports.com/report/cardiac-biomarkers-market/8024 This latest report researches the industry structure, sales, revenue,
Global Companion Diagnostic Cancer Biomarkers Market by types (Protein Biomarker …
Global Companion Diagnostic Cancer Biomarkers Market Research Report” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977. The report, titled Companion Diagnostic Cancer Biomarkers presents an in-depth study of the Companion Diagnostic Cancer Biomarkers market. Providing a brief history about the market, the report analyses the entire value chain of the market and points out the key drivers and restraints affecting the growth of the market during the forecast period. The report
Global Biomarkers Market Propelled by Growing Usage of Biomarkers in Medical Are …
A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body’s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions and help
Biomarkers Summit
SMi present their 4th annual conference on Biomarkers Summit Monday 31st January & Tuesday 1st February 2011 Crowne Plaza The-City, London, UK Don’t Miss Out - Visit to register your place today http://www.smi-online.co.uk/preclinical-biomarkers.asp Sponsored by Caprotec Cell Signalling Technology GVK Bio Selventa Millipore Quest Diagnostics RBM SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out